that was indeed five pages of complete dribble to try and disguise terrible financials, but anyone half competent will skip past that and go straight to the facts
it's one way to tell things are pretty bad when you have to pad up the quarterly with commentary that tries to change the topic from financials
got to feel for the poor investors who got suckered in with a pretty blonde
I guess she fooled even the "sophisticated" investors who participated in the CR at $4.5
kind of funny all the $30m cash "invested" in US treasury bills, yet they even managed to make a loss on that due to currency conversion
epic fail on all fronts
RIP indeed, what a farce
guess we'll see just how "priced in" this bad result really is
price and volume action suggest strong support around this price range, but i think that just may be some retail/trader hopefuls
- Forums
- ASX - By Stock
- 1PG
- Ann: 1PG Quarterly Commentary and Appendix 4C - 30 April 2016-1PG.AX
Ann: 1PG Quarterly Commentary and Appendix 4C - 30 April 2016-1PG.AX, page-14
-
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1PG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online